The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zhitkova Iu.V.

Mezhregional'nyĭ kliniko-diagnosticheskiĭ tsentr

Khasanova D.R.

Kazanskiĭ meditsinskiĭ gosudarstvennyĭ universitet

An experience of using mebicar in patients with autonomic dysfunction associated with anxiety disorder

Authors:

Zhitkova Iu.V., Khasanova D.R.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(11): 56‑63

DOI: 10.17116/jnevro201711711156-63

Read: 48998 times

Contact the author
Table of contents

AN EXPERIENCE OF USING MEBICAR IN PATIENTS WITH AUTONOMIC DYSFUNCTION ASSOCIATED WITH ANXIETY DISORDER
AN EXPERIENCE OF USING MEBICAR IN PATIENTS WITH AUTONOMIC DYSFUNCTION ASSOCIATED WITH ANXIETY DISORDER

To cite this article:

Zhitkova IuV, Khasanova DR. An experience of using mebicar in patients with autonomic dysfunction associated with anxiety disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(11):56‑63. (In Russ.)
https://doi.org/10.17116/jnevro201711711156-63

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Inve­stigation of the rela­tionship of indi­vidual characteristics of the brain bioelectrical acti­vity with levels of mental stress, aggression, anxiety, and depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):108-117
Psycho-emotional state and self-reported sleep quality in students with bimo­dality of the ability to be active in the morning and evening in the sleep—wake cycle. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):130-134
The pote­ntial of cortical electrical stimulation for the study of auto­nomic dysfunction in patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):25-34
Effe­cts of sema­glutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36
The rela­tionship between the inte­rictal para­meters of cardiovascular auto­nomic regu­lation and the outcomes of surgical treatment of epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):50-59
Basic and complex therapy of non-segmental viti­ligo with como­rbid anxiety and anxiety-depressive adju­stment diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):51-58
Resu­lts of the obse­rvational program CITO­TREK (use of the drug CITO­flavin in Tablets) in patients with tension headaches against the backgRound of asthenic syndromE taKing into account como­rbidity. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):104-112
Conscious seda­tion with benzodiazepines in pediatric outpatient dentistry. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):55-63
Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37
Abstract:

Background. Cognitive impairments are one of the most frequent and maladaptive factors in patients with autonomic dysfunction associated with anxiety disorder. The majority of anxiolytics manage to compensate anxiety but suppress cognitive functions. Material and methods. Fifty-four patients with autonomic dysfunction and anxiety disorder, including 39 women (mean age 25±6.7 years) and 15 men (mean age 27±8.4 years), were treated with mebicar during 3 months. Results and conclusion. A reduction in the degree of autonomic dysfunction and anxiety symptoms as well as a significant improvement of cognitive functions were noted. Mebicar showed a good tolerability and minimum drug-related adverse events, and can be recommended as a first line anti-anxiety remedy in wide clinical practice.

Keywords:

cognitive functions
anxiety
autonomic dysfunction
mebicar

Authors:

Zhitkova Iu.V.

Mezhregional'nyĭ kliniko-diagnosticheskiĭ tsentr

Khasanova D.R.

Kazanskiĭ meditsinskiĭ gosudarstvennyĭ universitet

Close metadata

References:

  1. Zimakova IE. Pharmacological effects of a new psychotropic drug mebicar. Farmakologiya i toksikologiya. 1977;6:634-637. (In Russ.)
  2. Kurashova SV, Zimakova IE. Mebikar — dnevnoi trankvilizator. M.: Finansy i statistika; 1990. (In Russ.)
  3. Mendelevich DM, Zimakova IE, Mendelevich VD. The use of the tranquilizer mebicar, for the treatment of climacteric neuro-psychiatric disorders. Akusherstvo i ginekologiya. 1983;2:51-53. (In Russ.)
  4. Venediktova MG, Tagirova TS. Evaluation of therapeutic effect of new domestic drug «Mebicar» with the cardialgia different genesis. Ekspress-informatsiya: Novye lekarstvennye preparaty. 1983;10:15-17. (In Russ.)
  5. Val’dman AV, Zaikonnikova IV, Kozlovskaya MM, Zimakova IE. Byul eksper biol. 1980;5:568-570. (In Russ.)
  6. Khaziakhmetova VN, Galiullina TN, Safina EG, Rodionova IR, Zimakova IE, Ziganshina LE. Randomized, placebo-controlled clinical trial hypolipidemic action and safety of the tranquilizer of day-time mebicar in patients with hypercholesterolemia. Klinicheskaya farmakologiya i terapiya. 2010;6:154-155. (In Russ.)
  7. Zimakova IE, Karpov AM, Tagirova TS, Salikhova RR, Zhilyaev AG. Analysis of the diversity of effects of the tranquilizer Mebicar in experimental and clinical medicine. Kazanskii meditsinskii zhurnal. 1995;2:XXVI:85-87. (In Russ.)
  8. Zimakova IE, Khaziakhmetova VN. Day tranquilizer Mebicar for the prevention of coronary heart disease. Terra Medica. 2002;3:7-8. (In Russ.)
  9. Karelin AA. Bol’shaya entsiklopediya psikhologicheskikh testov. M.: Eksmo. 2005. (In Russ.)
  10. Grober E, Sanders AE, Hall C, Lipton RB. Free and Cued Selective Reminding Identifies Very Mild Dementia in Primary Care. Alzheimer Dis Assoc Disord. 2010;24(3):284-290. https://doi.org/10.1097/wad.0b013e3181cfc78b
  11. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
  12. McNair D, Khan RJ. Self-assessment of cognitive deficit in geriatric psychopharmacology. Crook T., Ferris S., Bartus R. New Canaan, CT: Mark Powley Associaters Inc.; 1983.
  13. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia. 2011;7:270-279. https://doi.org/10.1016/j.jalz.2011.03.008
  14. Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41:1165-1174. https://doi.org/10.1017/s0033291710001911
  15. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25(6):1171-1180. https://doi.org/10.1017/s0033291700033146
  16. Duman RS, Monteggia LM. A Neurotrophic Model for Stress-Related Mood Disorders. Biol Psychiatry. 2006. https://doi.org/10.1016/j.biopsych.2006.02.013
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.